Expression, maturation, and rhodamine-based fluorescence assay of human cathepsin K expressed in CHO cells

Biochemical Pharmacology

Volumn 60, Issue 6, 2000, Pages 759-769

  Claveau, David ^a   Riendeau, Denis ^a   Mancini, Joseph A ^a  

^a MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

Author keywords

Bone resorption; Cathepsin; Cysteine protease; Osteoporosis; Papain

Indexed keywords

ALOXISTATIN; CATHEPSIN K; CYSTATIN; ENZYME INHIBITOR; ENZYME PRECURSOR; PROTEINASE; RECOMBINANT ENZYME; RHODAMINE;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CHO CELL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME RELEASE; FLUORESCENCE ACTIVATED CELL SORTER; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; VALIDATION PROCESS;

ANIMALS; CATHEPSIN B; CATHEPSINS; CHO CELLS; CRICETINAE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; RECOMBINANT PROTEINS; RHODAMINES; TRANSFECTION;

EID: 0034666717     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00381-6     Document Type: Article

References (28)

1. Delaisse J.M., Boyde A., Maconnachie E., Ali N.N., Sear C.H., Eeckhout Y., Vaes G., Jones S.J. The effects of inhibitors of cysteine-proteinases and collagenase on the resorptive activity of isolated osteoclasts. Bone. 8:1987;305-313.
2. Delaisse J.M., Eeckhout Y., Vaes G. In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorption. Biochem Biophys Res Commun. 125:1984;441-447.
3. Delaisse J.M., Eeckhout Y., Vaes G. Inhibition of bone resorption in culture by inhibitors of thiol proteinases. Biochem J. 192:1980;365-368.
4. Brömme D., Okamoto K. Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution. Biol Chem Hoppe Seyler. 376:1995;379-384.
5. Brömme D., Okamoto K., Wang B.B., Biroc S. Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme. J Biol Chem. 271:1996;2126-2132.
6. Drake F.H., Dodds R.A., James I.E., Connor J.R., Debouck C., Richardson S., Lee-Rykaczewski E., Coleman L., Rieman D., Barthlow R., Hastings G., Gowen M. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem. 271:1996;12511-12516.
7. Shi G.P., Chapman H.A., Bhairi S.M., DeLeeuw C., Reddy V.Y., Weiss S.J. Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2. FEBS Lett. 357:1995;129-134.
8. Tezuka K., Tezuka Y., Maejima A., Sato T., Nemoto K., Kamioka H., Hakeda Y., Kumegawa M. Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J Biol Chem. 269:1994;1106-1109.
9. Gelb B.D., Shi G.P., Chapman H.A., Desnick R.J. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science. 273:1996;1236-1238.
10. Johnson M.R., Polymeropoulos M.H., Vos H.L., Ortiz de Luna R.I., Francomano C.A. A nonsense mutation in the cathepsin K gene observed in a family with pycnodysostosis. Genome Res. 6:1996;1050-1055.
11. Littlewood-Evans A., Kokubo T., Ishibashi O., Inaoka T., Wlodarski B., Gallagher J.A., Bilbe G. Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry. Bone. 20:1997;81-86.
12. McQueney M.S., Amegadzie B.Y., D'Alessio K., Hanning C.R., McLaughlin M.M., McNulty D., Carr S.A., Ijames C., Kurdyla J., Jones C.S. Autocatalytic activation of human cathepsin K. J Biol Chem. 272:1997;13955-13960.
13. Bossard M.J., Tomaszek T.A., Thompson S.K., Amegadzie B.Y., Hanning C.R., Jones C., Kurdyla J.T., McNulty D.E., Drake F.H., Gowen M., Levy M.A. Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification. J Biol Chem. 271:1996;12517-12524.
14. 2 specificity of human cathepsin O2 in comparison with cathepsins S and L . Biochem J. 315:1996;85-89.
15. Kafienah W., Brömme D., Buttle D.J., Croucher L.J., Hollander A.P. Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem J. 331:1998;727-732.
16. Inui T., Ishibashi O., Inaoka T., Origane Y., Kumegawa M., Kokubo T., Yamamura T. Cathepsin K antisense oligodeoxynucleotide inhibits osteoclastic bone resorption. J Biol Chem. 272:1997;8109-8112.
17. McGrath M.E., Klaus J.L., Barnes M.G., Brömme D. Crystal structure of human cathepsin K complexed with a potent inhibitor. Nat Struct Biol. 4:1997;105-109.
18. Zhao B., Janson C.A., Amegadzie B.Y., D'Alessio K., Griffin C., Hanning C.R., Jones C., Kurdyla J., McQueney M., Qiu X., Smith W.W., Abdel-Meguid S.S. Crystal structure of human osteoclast cathepsin K complex with E-64. Nat Struct Biol. 4:1997;109-111.
19. Thompson S.K., Halbert S.M., Bossard M.J., Tomaszek T.A., Levy M.A., Zhao B., Smith W.W., Abdel-Meguid S.S., Janson C.A., D'Alessio K.J., McQueney M.S., Amegadzie B.Y., Hanning C.R., DesJarlais R.L., Briand J., Sarkar S.K., Huddleston M.J., Ijames C.F., Carr S.A., Garnes K.T., Shu A., Heys J.R., Bradbeer J., Zembryki D., Lee-Rykaczewski L., James I.E., Lark M.W., Drake F.H., Gowen M., Gleason J.G., Veber D.F. Design of potent and selective human cathepsin K inhibitors that span the active site. Proc Natl Acad Sci USA. 94:1997;14249-14254.
20. Nesbitt S.A., Horton M.A. Trafficking of matrix collagens through bone-resorbing osteoclasts. Science. 276:1997;266-269.
21. Salo J., Lehenkari P., Mulari M., Metsikko K., Vaananen H.K. Removal of osteoclast bone resorption products by transcytosis. Science. 276:1997;270-273.
22. Ulbricht B., Spiess E., Schwartz-Albeiz R., Ebert W. Quantification of intracellular cathepsin activities in human lung tumor cell lines by flow cytometry. Biol Chem Hoppe Seyler. 376:1995;407-414.
23. McGowan E.B., Becker E., Detwiler T.C. Inhibition of calpain in intact platelets by the thiol protease inhibitor E-64d. Biochem Biophys Res Commun. 158:1989;432-435.
24. Yamashita D.S., Smith W.W., Zhao B., Janson C.A., Tomaszek T.A., Bossard M.J., Levy M.A., Hye-Ja Oh, Carr T.J., Thompson S.K., Ijames C.F., Carr S.A., McQueney M., D'Alessio K.J., Amegdazie B.Y., Hanning C.R., Abdel-Meguid S., DesJarlais R.L., Gleason J.G., Veber D.F. Structure and design of potent and selective cathepsin K inhibitors. J Am Chem Soc. 119:1997;11351-11352.
25. Teitelbaum S.L., Tondravi M.M., Ross F.P. Osteoclasts, macrophages, and the molecular mechanisms of bone resorption. J Leukoc Biol. 61:1997;381-388.
26. Berti P.J., Storer A.C. Alignment/phylogeny of the papain superfamily of cysteine proteases. J Mol Biol. 246:1995;273-283.
27. Rifkin B.R., Vernillo A.T., Kleckner A.P., Auszmann J.M., Rosenberg L.R., Zimmerman M. Cathepsin B and L activities in isolated osteoclasts. Biochem Biophys Res Commun. 179:1991;63-69.
28. Saftig P., Hunziker E., Wehmeyer O., Jones S., Boyde A., Rommerskirch W., Moritz J.D., Schu P., von Figura K. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci USA. 95:1998;13453-13458.